IN THIS ISSUE

MargaretAnn Cross
As large companies become more demanding of health plans, clinical executives are increasingly being relied on to provide advice and expertise.
Jack McCain
Statin selection has just become more complicated. Will physicians be diverted from interventions that may be less costly and just as effective?
Editor's Memo
John Marcille
Legislation & Regulation
John Carroll
The Medicare amendment adopted late last year contains a provision that could help P&T committees, not to mention consumers, evaluate competing drugs.
Ethics
Michael S. Victoroff, MD
Discussing differing viewpoints brings a rich complexity to a rational exchange about whether it's ever right to deny life-saving treatment against someone's will.
Tomorrow's Medicine
Thomas Morrow, MD
After modest beginnings, transdermal patches are now taking advantage of nanotechnology and other novel techniques to improve drug delivery.
News and Commentary
News and Commentary